3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- manufacturers
|
| | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- Basic information |
| Product Name: | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- | | Synonyms: | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)-;Tofacitinib-3;Tofacitinib impurity 2/(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-aminehydrochloride;Azilsartan medoxomil impurity349;Tofacitinib Impurity 03;Tofatinib Impurity 34（HCI) | | CAS: | 1821769-41-8 | | MF: | C14H23ClN2 | | MW: | 254.8 | | EINECS: | | | Product Categories: | | | Mol File: | 1821769-41-8.mol |  |
| | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- Chemical Properties |
| | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- Usage And Synthesis |
| Uses | (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Dihydrochloride is the hydrochloride salt of (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine (B276220) which is an intermediate in the synthesis of (3S,4R)-Tofacitinib (T528010). (3S,4R)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. |
| | 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- Preparation Products And Raw materials |
|